Conroy Kevin T — SEC insider filings

SEC reporting owner CIK 1306119. 72 insider filings on record with FilingPulse; latest filed 2026-10-02.

Transaction summary — filings shown

Covers the 50 most recent of 72 filings on record, filed 2021-08-04 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
EXACT SCIENCES CORP (EXAS)President and CEO, Director331 leg · 19,500 sh · $1,001,32519 legs · 215,321 sh · $16,827,866100
ALIGN TECHNOLOGY INC (ALGN)Director4——10
Epizyme, Inc. (EPZM)Director6——8
ABBOTT LABORATORIES (ABT)Director4——4
Adaptive Biotechnologies Corp (ADPT)Director2——4
SomaLogic, Inc. (SLGCW)Director1——3

Insider filings — Conroy Kevin T

FiledFormIssuerReported transactionsSource
2026-10-024ABBOTT LABORATORIES (ABT)Grant/award (A): 318 (derivative) @ $98.83EDGAR
2026-09-254ABBOTT LABORATORIES (ABT)Tax withholding (F): 52,507 @ $103.99EDGAR
2026-07-014ABBOTT LABORATORIES (ABT)Grant/award (A): 231 (derivative) @ $90.74EDGAR
2026-05-224ALIGN TECHNOLOGY INC (ALGN)Option exercise (M): 1,745 @ $0 · Option exercise (M): 1,745 (derivative) @ $0 · Grant/award (A): 1,836 (derivative) @ $0EDGAR
2026-04-284ABBOTT LABORATORIES (ABT)Grant/award (A): 2,286 @ $0EDGAR
2026-03-234EXACT SCIENCES CORP (EXAS)Grant/award (A): 119,312 @ $0 · Disposition to issuer (D): 1,397,738 · Disposition to issuer (D): 29,061 · Disposition to issuer (D): 46,538 · Disposition to issuer (D): 86,750 · Disposition to issuer (D): 117,427 · +8 moreEDGAR
2026-03-034EXACT SCIENCES CORP (EXAS)Option exercise (M): 18,143 @ $0 · Tax withholding (F): 8,528 @ $103.25 · Option exercise (M): 22,168 @ $0 · Tax withholding (F): 10,419 @ $103.25 · Option exercise (M): 27,786 @ $0 · Tax withholding (F): 13,060 @ $103.25 · +3 moreEDGAR
2026-02-274EXACT SCIENCES CORP (EXAS)Grant/award (A): 13,181 @ $0 · Tax withholding (F): 6,196 @ $103.45 · Grant/award (A): 154,829 (derivative) @ $0EDGAR
2025-12-304EXACT SCIENCES CORP (EXAS)Grant/award (A): 244,931 @ $0 · Tax withholding (F): 115,118 @ $101.82 · Grant/award (A): 138,326 @ $0 · Tax withholding (F): 65,014 @ $101.82 · Grant/award (A): 330,674 @ $0 · Tax withholding (F): 155,417 @ $101.82EDGAR
2025-05-224ALIGN TECHNOLOGY INC (ALGN)Option exercise (M): 1,148 @ $0 · Option exercise (M): 1,148 (derivative) @ $0 · Grant/award (A): 1,745 (derivative) @ $0EDGAR
2025-03-104EXACT SCIENCES CORP (EXAS)Option exercise (M): 66,723 @ $22.38 · Tax withholding (F): 48,929 @ $47.06 · Option exercise (M): 66,723 (derivative) @ $0EDGAR
2025-03-044EXACT SCIENCES CORP (EXAS)Option exercise (M): 18,143 @ $0 · Tax withholding (F): 8,528 @ $47.82 · Option exercise (M): 22,167 @ $0 · Tax withholding (F): 10,419 @ $47.82 · Option exercise (M): 18,143 (derivative) @ $0 · Option exercise (M): 22,167 (derivative) @ $0EDGAR
2025-02-264EXACT SCIENCES CORP (EXAS)Option exercise (M): 13,180 @ $0 · Tax withholding (F): 6,195 @ $51.28 · Grant/award (A): 111,146 (derivative) @ $0 · Option exercise (M): 13,180 (derivative) @ $0EDGAR
2025-02-214EXACT SCIENCES CORP (EXAS)Option exercise (M): 10,374 @ $0 · Tax withholding (F): 3,271 @ $49.63 · Grant/award (A): 48,044 @ $0 · Tax withholding (F): 21,140 @ $50.48 · Option exercise (M): 10,374 (derivative) @ $0EDGAR
2024-11-134EXACT SCIENCES CORP (EXAS)Purchase (P): 19,500 @ $51.35EDGAR
2024-05-244ALIGN TECHNOLOGY INC (ALGN)Option exercise (M): 660 @ $0 · Option exercise (M): 660 (derivative) @ $0 · Grant/award (A): 1,148 (derivative) @ $0EDGAR
2024-05-024EXACT SCIENCES CORP (EXAS)Grant/award (A): 2,489 @ $0 · Grant/award (A): 708 @ $30.02 · Sale (S): 1,155 @ $60.15EDGAR
2024-03-044EXACT SCIENCES CORP (EXAS)Option exercise (M): 18,143 @ $0 · Sale (S): 8,271 @ $59.32 · Option exercise (M): 18,143 (derivative) @ $0EDGAR
2024-02-284EXACT SCIENCES CORP (EXAS)Option exercise (M): 13,181 @ $0 · Sale (S): 6,263 @ $56.89 · Option exercise (M): 13,181 (derivative) @ $0 · Grant/award (A): 88,671 (derivative) @ $0EDGAR
2024-02-264EXACT SCIENCES CORP (EXAS)Option exercise (M): 102,837 @ $13.96 · Tax withholding (F): 61,560 @ $57.53 · Option exercise (M): 102,837 (derivative) @ $0EDGAR
2024-02-234EXACT SCIENCES CORP (EXAS)Grant/award (A): 23,238 @ $0 · Sale (S): 11,565 @ $59.78EDGAR
2024-02-224EXACT SCIENCES CORP (EXAS)Option exercise (M): 10,374 @ $0 · Sale (S): 4,975 @ $61.50 · Option exercise (M): 10,374 (derivative) @ $0EDGAR
2024-02-164EXACT SCIENCES CORP (EXAS)Grant/award (A): 709 @ $30.02 · Option exercise (M): 31,133 @ $0 · Sale (S): 14,791 @ $61.43 · Option exercise (M): 31,133 (derivative) @ $0EDGAR
2023-12-074ALIGN TECHNOLOGY INC (ALGN)Grant/award (A): 660 (derivative) @ $0EDGAR
2023-03-084Adaptive Biotechnologies Corp (ADPT)Grant/award (A): 14,775 @ $0 · Grant/award (A): 23,329 (derivative) @ $0EDGAR
2023-03-014EXACT SCIENCES CORP (EXAS)Option exercise (M): 13,180 @ $0 · Option exercise (M): 9,312 @ $0 · Sale (S): 10,416 @ $61.12 · Option exercise (M): 13,180 (derivative) @ $0 · Option exercise (M): 9,312 (derivative) @ $0EDGAR
2023-02-284EXACT SCIENCES CORP (EXAS)Grant/award (A): 72,572 (derivative) @ $0EDGAR
2023-02-234EXACT SCIENCES CORP (EXAS)Option exercise (M): 10,374 @ $0 · Sale (S): 4,764 @ $62.72 · Option exercise (M): 10,374 (derivative) @ $0EDGAR
2023-02-164EXACT SCIENCES CORP (EXAS)Option exercise (M): 31,132 @ $0 · Sale (S): 14,617 @ $65.59 · Option exercise (M): 31,132 (derivative) @ $0EDGAR
2023-02-144EXACT SCIENCES CORP (EXAS)Option exercise (M): 9,705 @ $0 · Sale (S): 4,527 @ $64.55 · Option exercise (M): 9,705 (derivative) @ $0EDGAR
2022-08-164Epizyme, Inc. (EPZM)Disposition to issuer (D): 53,324 · Disposition to issuer (D): 8,994EDGAR
2022-07-064EXACT SCIENCES CORP (EXAS)Grant/award (A): 328 @ $47.41 · Sale (S): 7 @ $40.75EDGAR
2022-07-054Epizyme, Inc. (EPZM)Grant/award (A): 10,204 @ $1.47EDGAR
2022-05-194Epizyme, Inc. (EPZM)Grant/award (A): 8,994 @ $0 · Grant/award (A): 41,006 (derivative) @ $0EDGAR
2022-04-014Epizyme, Inc. (EPZM)Grant/award (A): 13,043 @ $1.15EDGAR
2022-03-184EXACT SCIENCES CORP (EXAS)Option exercise (M): 229,757 @ $5.70 · Option exercise (M): 4,612 @ $21.68 · Option exercise (M): 2,253 @ $44.37 · Option exercise (M): 229,757 (derivative) @ $0 · Option exercise (M): 4,612 (derivative) @ $0 · Option exercise (M): 2,253 (derivative) @ $0EDGAR
2022-03-024EXACT SCIENCES CORP (EXAS)Option exercise (M): 20,575 @ $0 · Option exercise (M): 9,312 @ $0 · Sale (S): 14,299 @ $76.69 · Option exercise (M): 20,575 (derivative) @ $0 · Option exercise (M): 9,312 (derivative) @ $0EDGAR
2022-03-014EXACT SCIENCES CORP (EXAS)Grant/award (A): 52,722 (derivative) @ $0EDGAR
2022-02-254EXACT SCIENCES CORP (EXAS)Option exercise (M): 58,643 @ $0 · Sale (S): 27,126 @ $70.10 · Option exercise (M): 58,643 (derivative) @ $0EDGAR
2022-02-244EXACT SCIENCES CORP (EXAS)Option exercise (M): 10,373 @ $0 · Sale (S): 5,188 @ $69.05 · Option exercise (M): 10,373 (derivative) @ $0EDGAR
2022-02-164EXACT SCIENCES CORP (EXAS)Option exercise (M): 94,425 @ $9.07 · Option exercise (M): 96,758 @ $10.82 · Option exercise (M): 31,133 @ $78.33 · Sale (S): 14,409 @ $79.55 · Option exercise (M): 94,425 (derivative) @ $0 · Option exercise (M): 96,758 (derivative) @ $0 · +1 moreEDGAR
2022-01-284Adaptive Biotechnologies Corp (ADPT)Grant/award (A): 6,689 @ $0 · Grant/award (A): 16,722 (derivative) @ $0EDGAR
2022-01-194EXACT SCIENCES CORP (EXAS)Grant/award (A): 6,407 @ $0EDGAR
2022-01-044Epizyme, Inc. (EPZM)Grant/award (A): 6,000 @ $2.50EDGAR
2021-11-034EXACT SCIENCES CORP (EXAS)Sale (S): 16,922 @ $93.88EDGAR
2021-10-054EXACT SCIENCES CORP (EXAS)Sale (S): 17,078 @ $93.64EDGAR
2021-10-014Epizyme, Inc. (EPZM)Grant/award (A): 2,930 @ $5.12EDGAR
2021-09-034EXACT SCIENCES CORP (EXAS)Sale (S): 18,978 @ $104.42EDGAR
2021-09-034SomaLogic, Inc. (SLGCW)Other (J): 25,000 @ $0 · Grant/award (A): 166,666 (derivative) · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2021-08-044EXACT SCIENCES CORP (EXAS)Sale (S): 19,970 @ $107.50EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1306119 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs